Predictive Oncology (POAI) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChartTranscripts

Predictive Oncology Revenue Highlights


Latest Revenue (Y)

$1.78M

Latest Revenue (Q)

$419.65K

Main Segment (Y)

Pittsburgh

Main Geography (Y)

Skyline

Predictive Oncology Revenue by Period


Predictive Oncology Revenue by Year

DateRevenueChange
2023-12-31$1.78M18.24%
2022-12-31$1.51M5.97%
2021-12-31$1.42M13.45%
2020-12-31$1.25M-11.28%
2019-12-31$1.41M-0.01%
2018-12-31$1.41M115.57%
2017-12-31$654.84K43.45%
2016-12-31$456.50K-30.24%
2015-12-31$654.35K-31.23%
2014-12-31$951.56K103.27%
2013-12-31$468.13K147.98%
2012-12-31$188.77K95.34%
2011-12-31$96.64K33454.51%
2010-12-31$288.00-98.17%
2009-12-31$15.74K100.00%
2008-12-31--

Predictive Oncology generated $1.78M in revenue during NA 2023, up 18.24% compared to the previous quarter, and up 126.10% compared to the same period a year ago.

Predictive Oncology Revenue by Quarter

DateRevenueChange
2024-03-31$419.65K25.26%
2023-12-31$335.03K-53.15%
2023-09-30$715.06K45.90%
2023-06-30$490.11K104.30%
2023-03-31$239.90K-34.00%
2022-12-31$363.47K-20.26%
2022-09-30$455.83K22.67%
2022-06-30$371.59K18.13%
2022-03-31$314.57K-33.98%
2021-12-31$476.49K51.91%
2021-09-30$313.66K-10.43%
2021-06-30$350.21K24.93%
2021-03-31$280.32K-4.59%
2020-12-31$293.79K-38.89%
2020-09-30$480.76K163.02%
2020-06-30$182.78K-38.03%
2020-03-31$294.94K-15.12%
2019-12-31$347.48K-33.52%
2019-09-30$522.70K82.66%
2019-06-30$286.15K12.11%
2019-03-31$255.24K-18.07%
2018-12-31$311.55K-5.57%
2018-09-30$329.93K-7.99%
2018-06-30$358.59K-12.88%
2018-03-31$411.59K86.82%
2017-12-31$220.31K44.43%
2017-09-30$152.53K42.79%
2017-06-30$106.82K-39.02%
2017-03-31$175.17K25.51%
2016-12-31$139.56K3.68%
2016-09-30$134.60K57.58%
2016-06-30$85.42K-11.85%
2016-03-31$96.91K-47.13%
2015-12-31$183.28K113.63%
2015-09-30$85.79K-63.34%
2015-06-30$234.01K54.69%
2015-03-31$151.27K-8.76%
2014-12-31$165.79K-58.27%
2014-09-30$397.25K24.81%
2014-06-30$318.29K353.28%
2014-03-31$70.22K-14.06%
2013-12-31$81.71K-24.23%
2013-09-30$107.83K-28.52%
2013-06-30$150.86K18.11%
2013-03-31$127.73K42.61%
2012-12-31$89.56K73.52%
2012-09-30$51.62K106.79%
2012-06-30$24.96K10.27%
2012-03-31$22.64K-69.41%
2011-12-31$74.00K265.17%
2011-09-30$20.26K753.58%
2011-06-30$2.37K100.00%
2011-03-31-100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30--100.00%
2010-03-31$288.00100.00%
2009-12-31-100.00%
2009-09-30--100.00%
2009-06-30$15.74K100.00%
2009-03-31-100.00%
2008-12-31-100.00%
2008-09-30--

Predictive Oncology generated $419.65K in revenue during Q1 2024, up 25.26% compared to the previous quarter, and up 115.45% compared to the same period a year ago.

Predictive Oncology Revenue Breakdown


Predictive Oncology Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Pittsburgh$492.60K----
Helomics Segment-$6.40K$13.37K$64.19K$48.45K
zPREDICTA-$352.38K$90.00--
Soluble-$82.30K$233.29K$2.87K-
Skyline-$1.06M$1.17M$1.19M-
International----$88.07K
Domestic----$1.28M

Predictive Oncology's latest annual revenue breakdown by segment (product or service), as of Dec 23: Pittsburgh (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Pittsburgh$67.25K$4.86K$51.03K$417.10K$13.84K$10.63K--------------
Helomics Segment------$854.00$1.82K$84.00$3.64K$2.05K$2.16K$7.16K$1.99K$30.31K$9.70K$9.05K$15.13K--
zPREDICTA------$91.28K$170.82K$71.94K$18.34K----------
Soluble------$17.72K$29.44K$22.23K$12.92K$156.65K$27.65K$34.91K$14.07K------
Skyline------$253.62K$253.75K$276.85K$279.27K$316.75K$282.68K$306.14K$264.25K$260.61K$471.05K----
Domestic----------------$173.74K$279.81K$340.43K$455.88K
International------------------$11.02K$40.01K
Other Segments-------------------$26.81K

Predictive Oncology's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Pittsburgh (100.00%).

Predictive Oncology Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 22Dec 19
zPREDICTA$352.38K-
Helomics Segment$6.40K-
Skyline$1.06M-
Soluble$82.30K-
Domestic-$1.28M

Predictive Oncology's latest annual revenue breakdown by geography, as of Dec 22: Skyline (70.68%), zPREDICTA (23.42%), Soluble (5.47%), and Helomics Segment (0.43%).

Quarterly Revenue by Country

CountryJun 20Mar 20Dec 19Sep 19Jun 19Mar 19Sep 18Jun 18
Domestic$173.74K$279.81K$340.43K$455.88K$259.08K$219.66K--
Non-US------$4.20K$3.18K

Predictive Oncology's latest quarterly revenue breakdown by geography, as of Jun 20: Domestic (100.00%).

Predictive Oncology Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
ISRGIntuitive Surgical$7.12B$2.04B
PDEXPro-Dex$53.84M$14.89M
BNGOBionano Genomics$36.12M$7.77M
DXRDaxor$34.59M$36.35M
ZJYLJin Medical$19.82M$9.57M
GMVDG Medical Innovations$4.42M$-128.35K
NYXHNyxoah$4.30M$1.22M
NXGLNEXGEL$4.09M$1.44M
POAIPredictive Oncology$1.78M$419.65K
LUCYInnovative Eyewear$1.15M$308.68M
GCTKGlucoTrack--
MBOTMicrobot Medical--
STSSSharps--

POAI Revenue FAQ


Predictive Oncology's yearly revenue for 2023 was $1.78M, representing an increase of 18.24% compared to 2022. The company's yearly revenue for 2022 was $1.51M, representing an increase of 5.97% compared to 2021. POAI's yearly revenue for 2021 was $1.42M, representing an increase of 13.45% compared to 2020.

Predictive Oncology's quarterly revenue for Q1 2024 was $419.65K, a 25.26% increase from the previous quarter (Q4 2023), and a 74.93% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $335.03K, a -53.15% decrease from the previous quarter (Q3 2023), and a -7.82% decrease year-over-year (Q4 2022). POAI's quarterly revenue for Q3 2023 was $715.06K, a 45.90% increase from the previous quarter (Q2 2023), and a 56.87% increase year-over-year (Q3 2022).

Predictive Oncology's revenue growth rate for the last 3 years (2021-2023) was 25.30%, and for the last 5 years (2019-2023) was 26.11%.

Predictive Oncology's revenue streams in c 23 are Pittsburgh

For the fiscal year ending Dec 23, the largest source of revenue of Predictive Oncology was Pittsburgh. This segment made a revenue of $492.6K, representing 100.00% of the company's total revenue.